BioEcho develops single-spin and 96/384-well kits based on the proprietary single-step EchoLUTION nucleic acid extraction process. Highly superior to the commonly used Silica-based solutions (bind-wash-elute), the whole procedure is extremely fast. Washing steps are not required and the isolated inhibitor-free RNA/DNA is detected with increased sensitivity. Due to the expertise of its founders and employees, BioEcho also uses their know-how to support companies with limited research capacities or specialized scientific knowledge. Especially in times like these, BioEcho helps to accelerate accurate tests on certain RNA/DNA viruses or pathogens.
4Teen4’s DPP3 predicts burn mortality
Latest News4TEEN4 Pharmaceuticals GmbH published data suggesting that high plasma levels of dipeptidyl peptidase 3 were indicative for upcoming multiple organ failure in burn patients.
Genentech: New Head of Research and Early Development
AppointmentsAviv Regev will follow Michael Varney as Head of Genentech Research and Early Development (gRED) at Roche subsidiary Genentech. Varney will retire from the company at the end of July.
IMI ramps up COVID fund
Latest NewsThe funding pot of the Innovation Medicines Initiative has been boosted to €117m. IMI has also selected eight projects to fund.
Growing interest in alternative meat market
BackgroundManufacturers are keen to get involved in the alternative meat market. Investors and incubators are pushing forward start-ups.
Upscaling in the race to cultured meat
BackgroundA first wave of cultured meat companies is pushing forward. European start-ups such as Mosa Meat and Peace of Meat are part of the game.
New CEO at Deinove
AppointmentsMontpellier-based Deinove has named a new Chief Executive Officer. Alexis Rideau took over the helm of the company in the beginning of May.
S-Protein: Glycosylation pattern revealed
Latest NewsBritish researchers have deciphered the glycosylation pattern of the viral spike protein of SARS-CoV-2 laying the foundation for vaccine development.
Newron terminates sarizotan development in Rett syndrome
Latest NewsNewron Pharmaceuticals S.p.A.s Sarizotan failed to meet efficacy endpoints in the Phase III STARS study.
Roche gets FDA okay for COVID-19 antibody test
Latest NewsRoche Diagnostics has received FDA Emergency use approval for its highly specific Elecsys antibody test.
BioEcho Focus on extremely fast DNA/RNA tests
Sponsored PublicationsBioEcho develops single-spin and 96/384-well kits based on the proprietary single-step EchoLUTION nucleic acid extraction process. Highly superior to the commonly used Silica-based solutions (bind-wash-elute), the whole procedure is extremely fast. Washing steps are not required and the isolated inhibitor-free RNA/DNA is detected with increased sensitivity. Due to the expertise of its founders and employees, BioEcho also uses their know-how to support companies with limited research capacities or specialized scientific knowledge. Especially in times like these, BioEcho helps to accelerate accurate tests on certain RNA/DNA viruses or pathogens.